Ian Karp
Public Communications Contact bij INTELLIA THERAPEUTICS, INC.
Profiel
Ian Karp is currently the Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. He previously worked as the Senior Director-Global Marketing at Medimmune, Inc. and as the Vice President & Head-Investor Relations at Shire Plc.
He also served as the Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc. Mr. Karp received his undergraduate degree from Emory University and his MBA from Rutgers Business School.
Actieve functies van Ian Karp
| Bedrijven | Functie | Begin |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - |
Eerdere bekende functies van Ian Karp
| Bedrijven | Functie | Einde |
|---|---|---|
| SHIRE | Investor Relations Contact | 01-12-2017 |
| Medimmune, Inc. | Verkoop & Marketing | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | - |
Opleiding van Ian Karp
| Emory University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Medimmune, Inc. | Health Technology |
